Evaluation of Vestibular Dysfunction or Visuospatial Perception in Individuals With Idiopathic Scoliosis

NCT05045014 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2022-01-14

No results posted yet for this study

Summary

This study was planned to investigate whether there is a visual-spatial perception disorder in individuals with idiopathic scoliosis and also to reveal its dependent/independent relationship with vestibular dysfunction.

Conditions

  • Scoliosis Idiopathic
  • Vestibular Function Disorder
  • Visuospatial/Perceptual Abilities

Interventions

OTHER

Balance assessment

Romberg test and one-leg standing test will be used.

OTHER

Unterberger test

During 50 steps, he will count in place with 45 degrees of hip flexion, and after 50 steps, the angle of rotation between the first position and the final position of the right foot will be measured with the help of a goniometer and the displacement distance.

OTHER

Corsi Block Tapping (mobıl app)

Spatial memory will be evaluated.

OTHER

Navigation performance

Two triangles (one equilateral, one oblique triangle, at 30°, 60° and 90° angles respectively) with route segment lengths between 150 and 300 cm will be marked on the floor and the participants will be asked to complete the task with their eyes closed. The final deviation amount will be recorded.

OTHER

Cobb angle measurement

It will be evaluated with the help of X-ray.

OTHER

Scolio Detector (mobıl app)

The degree of rotation will be measured with the mobile application called Scolio Detector.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Burcu TALU · Inonu University

Eligibility

Min Age
10 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-04-15
Completion
2022-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05045014 on ClinicalTrials.gov